Atlas Venture Life Science Advisors, LLC has filed its 13F form on February 06, 2025 for Q4 2024 where it was disclosed a total value porftolio of $606 Million distributed in 13 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Kymera Therapeutics, Inc. with a value of $197M, Dyne Therapeutics, Inc. with a value of $189M, Third Harmonic Bio, Inc. with a value of $107M, Day One Biopharmaceuticals, Inc. with a value of $81.5M, and Vigil Neuroscience, Inc. with a value of $9.81M.

Examining the 13F form we can see an decrease of $204M in the current position value, from $810M to 606M.

Below you can find more details about Atlas Venture Life Science Advisors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $606 Million
Healthcare: $606 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 13
  • Current Value $606 Million
  • Prior Value $810 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 06, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Atlas Venture Life Science Advisors, LLC Portfolio

Follow Atlas Venture Life Science Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Venture Life Science Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Venture Life Science Advisors, LLC with notifications on news.